Tuesday, 9 May 2017

Natco Pharma launches generic hepatitis C drug

Natco Pharma on Monday said it has launched a generic version of sofosbuvir 400 mg/velpatasvir 100 mg tablets in India, which is used for treatment of chronic hepatitis C virus (HCV) infection. The pharmaceutical company said in a regulatory filing to the BSE that it will market the sofosbuvir 400 mg/velpatasvir 100 mg fixed dose combination in India under the brand name 'Velpanat'. Financial Advisory which means a lot to a Financial trader and we can do a best with your investments with all mandatory work skills subscribe us now and get two days Free Trial >> http://www.ripplesadvisory.com/free-trial.php

No comments:

Post a Comment